Kabutan

アイリズムが大幅高 心拍計「Zio・XT」利用における保険適用額の ...

医療用機器のアイリズム・テクノロジーズ<IRTC>が大幅高。医療機関が同社の心拍計「Zio・XT」を使用した場合の保険適用額について、米国の公的医療保険のメディケア・メディケイド・サービスセンター（CMS）が従来の233ドルから246ドル ...
National Institute for Health and Care Excellence

Zio XT for detecting cardiac arrhythmias

3.1 The clinical evidence comprises 17 published studies, which include 169,063 people referred to ambulatory monitoring, and 13 abstracts: 3.2 Three of the 4 comparative studies compared 14‑day Zio ...
Nasdaq

Additional studies presented at ACC.23/WCC reinforce the clinical value of the Zio suite of ...

SAN FRANCISCO, March 06, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health company focused on creating trusted solutions that detect, predict, and prevent ...
Yahoo Finance

iRhythm Unveils Data Demonstrating Superior Real-World Performance of Next-Generation Zio ...

SAN FRANCISCO, Sept. 09, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) today announced initial research findings on post-market, real-world performance of Zio ® monitor, its ...
Yahoo Finance

Large Real-World Evidence Analysis Demonstrates that Zio® XT Is Associated With the ...

SAN FRANCISCO, March 06, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health company focused on creating trusted solutions that detect, predict, and prevent ...
WKRG

NAMCP Independent Third-Party Review Validates Value Proposition of iRhythm Zio XT Service ...

SAN FRANCISCO, July 18, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent ...